Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Affimed signs up to $5bn cancer therapeutics deal with Genentech

pharmaceuticalAugust 30, 2018

Tag: Genentech , cancer therapeutics

PharmaSources Customer Service